nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—CYP2D6—breast cancer	0.433	1	CbGaD
Pindolol—CYP2D6—Idarubicin—breast cancer	0.024	0.414	CbGbCtD
Pindolol—CYP2D6—Vinorelbine—breast cancer	0.0117	0.202	CbGbCtD
Pindolol—CYP2D6—Tamoxifen—breast cancer	0.0106	0.183	CbGbCtD
Pindolol—CYP2D6—Vinblastine—breast cancer	0.00721	0.125	CbGbCtD
Pindolol—CYP2D6—Doxorubicin—breast cancer	0.00443	0.0766	CbGbCtD
Pindolol—Carteolol—CYP2D6—breast cancer	0.000589	0.102	CrCbGaD
Pindolol—Betaxolol—CYP2D6—breast cancer	0.000462	0.0801	CrCbGaD
Pindolol—Bisoprolol—CYP2D6—breast cancer	0.000446	0.0774	CrCbGaD
Pindolol—Acebutolol—CYP2D6—breast cancer	0.000422	0.0733	CrCbGaD
Pindolol—Oxprenolol—CYP2D6—breast cancer	0.000419	0.0728	CrCbGaD
Pindolol—Alprenolol—CYP2D6—breast cancer	0.000384	0.0665	CrCbGaD
Pindolol—Bisoprolol—CYP3A4—breast cancer	0.000383	0.0664	CrCbGaD
Pindolol—Nadolol—ABCB1—breast cancer	0.000375	0.065	CrCbGaD
Pindolol—Metoprolol—CYP2D6—breast cancer	0.000357	0.0619	CrCbGaD
Pindolol—Isoprenaline—CYP1A1—breast cancer	0.00034	0.059	CrCbGaD
Pindolol—Atenolol—ABCB1—breast cancer	0.000327	0.0567	CrCbGaD
Pindolol—Acebutolol—ABCB1—breast cancer	0.000302	0.0523	CrCbGaD
Pindolol—Metoprolol—ABCB1—breast cancer	0.000255	0.0442	CrCbGaD
Pindolol—Propranolol—CYP1A1—breast cancer	0.000242	0.042	CrCbGaD
Pindolol—Propranolol—CYP2D6—breast cancer	0.00018	0.0312	CrCbGaD
Pindolol—Asthenia—Irinotecan—breast cancer	0.000178	0.00045	CcSEcCtD
Pindolol—Asthenia—Mitoxantrone—breast cancer	0.000178	0.00045	CcSEcCtD
Pindolol—Conjunctivitis—Epirubicin—breast cancer	0.000176	0.000446	CcSEcCtD
Pindolol—Dry mouth—Docetaxel—breast cancer	0.000175	0.000443	CcSEcCtD
Pindolol—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000175	0.000442	CcSEcCtD
Pindolol—Fatigue—Paclitaxel—breast cancer	0.000175	0.000441	CcSEcCtD
Pindolol—Sweating—Epirubicin—breast cancer	0.000174	0.00044	CcSEcCtD
Pindolol—Pollakiuria—Doxorubicin—breast cancer	0.000174	0.00044	CcSEcCtD
Pindolol—Asthenia—Gemcitabine—breast cancer	0.000174	0.000439	CcSEcCtD
Pindolol—Myalgia—Capecitabine—breast cancer	0.000173	0.000438	CcSEcCtD
Pindolol—Chest pain—Capecitabine—breast cancer	0.000173	0.000438	CcSEcCtD
Pindolol—Arthralgia—Capecitabine—breast cancer	0.000173	0.000438	CcSEcCtD
Pindolol—Constipation—Paclitaxel—breast cancer	0.000173	0.000438	CcSEcCtD
Pindolol—Pain—Paclitaxel—breast cancer	0.000173	0.000438	CcSEcCtD
Pindolol—Confusional state—Docetaxel—breast cancer	0.000173	0.000437	CcSEcCtD
Pindolol—Anxiety—Capecitabine—breast cancer	0.000173	0.000437	CcSEcCtD
Pindolol—Oedema—Docetaxel—breast cancer	0.000172	0.000434	CcSEcCtD
Pindolol—Weight increased—Doxorubicin—breast cancer	0.000171	0.000433	CcSEcCtD
Pindolol—Pruritus—Gemcitabine—breast cancer	0.000171	0.000432	CcSEcCtD
Pindolol—Nausea—Thiotepa—breast cancer	0.000171	0.000432	CcSEcCtD
Pindolol—Diarrhoea—Mitoxantrone—breast cancer	0.00017	0.000429	CcSEcCtD
Pindolol—Diarrhoea—Irinotecan—breast cancer	0.00017	0.000429	CcSEcCtD
Pindolol—Dry mouth—Capecitabine—breast cancer	0.00017	0.000428	CcSEcCtD
Pindolol—Shock—Docetaxel—breast cancer	0.000169	0.000427	CcSEcCtD
Pindolol—Nervous system disorder—Docetaxel—breast cancer	0.000168	0.000425	CcSEcCtD
Pindolol—Pruritus—Fluorouracil—breast cancer	0.000168	0.000425	CcSEcCtD
Pindolol—Drowsiness—Doxorubicin—breast cancer	0.000168	0.000424	CcSEcCtD
Pindolol—Visual impairment—Methotrexate—breast cancer	0.000168	0.000424	CcSEcCtD
Pindolol—Confusional state—Capecitabine—breast cancer	0.000168	0.000423	CcSEcCtD
Pindolol—Tachycardia—Docetaxel—breast cancer	0.000168	0.000423	CcSEcCtD
Pindolol—Feeling abnormal—Paclitaxel—breast cancer	0.000167	0.000422	CcSEcCtD
Pindolol—Oedema—Capecitabine—breast cancer	0.000166	0.00042	CcSEcCtD
Pindolol—Bradycardia—Epirubicin—breast cancer	0.000166	0.000419	CcSEcCtD
Pindolol—Gastrointestinal pain—Paclitaxel—breast cancer	0.000166	0.000418	CcSEcCtD
Pindolol—Diarrhoea—Gemcitabine—breast cancer	0.000166	0.000418	CcSEcCtD
Pindolol—Dizziness—Irinotecan—breast cancer	0.000164	0.000415	CcSEcCtD
Pindolol—Shock—Capecitabine—breast cancer	0.000164	0.000413	CcSEcCtD
Pindolol—Conjunctivitis—Doxorubicin—breast cancer	0.000163	0.000413	CcSEcCtD
Pindolol—Nervous system disorder—Capecitabine—breast cancer	0.000163	0.000412	CcSEcCtD
Pindolol—Diarrhoea—Fluorouracil—breast cancer	0.000163	0.000411	CcSEcCtD
Pindolol—Tinnitus—Methotrexate—breast cancer	0.000162	0.00041	CcSEcCtD
Pindolol—Tachycardia—Capecitabine—breast cancer	0.000162	0.00041	CcSEcCtD
Pindolol—Cardiac disorder—Methotrexate—breast cancer	0.000162	0.000408	CcSEcCtD
Pindolol—Sweating—Doxorubicin—breast cancer	0.000161	0.000407	CcSEcCtD
Pindolol—Hyperhidrosis—Capecitabine—breast cancer	0.000161	0.000406	CcSEcCtD
Pindolol—Hypotension—Docetaxel—breast cancer	0.00016	0.000405	CcSEcCtD
Pindolol—Abdominal pain—Paclitaxel—breast cancer	0.00016	0.000405	CcSEcCtD
Pindolol—Angiopathy—Methotrexate—breast cancer	0.000158	0.000399	CcSEcCtD
Pindolol—Vomiting—Mitoxantrone—breast cancer	0.000158	0.000399	CcSEcCtD
Pindolol—Vomiting—Irinotecan—breast cancer	0.000158	0.000399	CcSEcCtD
Pindolol—Dizziness—Fluorouracil—breast cancer	0.000157	0.000397	CcSEcCtD
Pindolol—Visual impairment—Epirubicin—breast cancer	0.000157	0.000397	CcSEcCtD
Pindolol—Mediastinal disorder—Methotrexate—breast cancer	0.000157	0.000397	CcSEcCtD
Pindolol—Rash—Mitoxantrone—breast cancer	0.000157	0.000396	CcSEcCtD
Pindolol—Rash—Irinotecan—breast cancer	0.000157	0.000396	CcSEcCtD
Pindolol—Dermatitis—Mitoxantrone—breast cancer	0.000156	0.000395	CcSEcCtD
Pindolol—Dermatitis—Irinotecan—breast cancer	0.000156	0.000395	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000156	0.000395	CcSEcCtD
Pindolol—Headache—Mitoxantrone—breast cancer	0.000156	0.000393	CcSEcCtD
Pindolol—Headache—Irinotecan—breast cancer	0.000156	0.000393	CcSEcCtD
Pindolol—Hypotension—Capecitabine—breast cancer	0.000155	0.000392	CcSEcCtD
Pindolol—Insomnia—Docetaxel—breast cancer	0.000155	0.000392	CcSEcCtD
Pindolol—Propranolol—CYP3A4—breast cancer	0.000154	0.0268	CrCbGaD
Pindolol—Paraesthesia—Docetaxel—breast cancer	0.000154	0.00039	CcSEcCtD
Pindolol—Vomiting—Gemcitabine—breast cancer	0.000154	0.000389	CcSEcCtD
Pindolol—Bradycardia—Doxorubicin—breast cancer	0.000154	0.000388	CcSEcCtD
Pindolol—Dyspnoea—Docetaxel—breast cancer	0.000153	0.000387	CcSEcCtD
Pindolol—Somnolence—Docetaxel—breast cancer	0.000153	0.000386	CcSEcCtD
Pindolol—Mental disorder—Methotrexate—breast cancer	0.000153	0.000386	CcSEcCtD
Pindolol—Rash—Gemcitabine—breast cancer	0.000153	0.000385	CcSEcCtD
Pindolol—Dermatitis—Gemcitabine—breast cancer	0.000152	0.000385	CcSEcCtD
Pindolol—Tinnitus—Epirubicin—breast cancer	0.000152	0.000384	CcSEcCtD
Pindolol—Headache—Gemcitabine—breast cancer	0.000152	0.000383	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000151	0.000383	CcSEcCtD
Pindolol—Cardiac disorder—Epirubicin—breast cancer	0.000151	0.000382	CcSEcCtD
Pindolol—Vomiting—Fluorouracil—breast cancer	0.000151	0.000382	CcSEcCtD
Pindolol—Dyspepsia—Docetaxel—breast cancer	0.000151	0.000382	CcSEcCtD
Pindolol—Insomnia—Capecitabine—breast cancer	0.00015	0.00038	CcSEcCtD
Pindolol—Rash—Fluorouracil—breast cancer	0.00015	0.000379	CcSEcCtD
Pindolol—Dermatitis—Fluorouracil—breast cancer	0.00015	0.000379	CcSEcCtD
Pindolol—Paraesthesia—Capecitabine—breast cancer	0.000149	0.000377	CcSEcCtD
Pindolol—Headache—Fluorouracil—breast cancer	0.000149	0.000377	CcSEcCtD
Pindolol—Gastrointestinal disorder—Docetaxel—breast cancer	0.000148	0.000375	CcSEcCtD
Pindolol—Dyspnoea—Capecitabine—breast cancer	0.000148	0.000374	CcSEcCtD
Pindolol—Fatigue—Docetaxel—breast cancer	0.000148	0.000374	CcSEcCtD
Pindolol—Angiopathy—Epirubicin—breast cancer	0.000148	0.000374	CcSEcCtD
Pindolol—Nausea—Mitoxantrone—breast cancer	0.000148	0.000373	CcSEcCtD
Pindolol—Nausea—Irinotecan—breast cancer	0.000148	0.000373	CcSEcCtD
Pindolol—Mediastinal disorder—Epirubicin—breast cancer	0.000147	0.000371	CcSEcCtD
Pindolol—Constipation—Docetaxel—breast cancer	0.000147	0.000371	CcSEcCtD
Pindolol—Pain—Docetaxel—breast cancer	0.000147	0.000371	CcSEcCtD
Pindolol—Dyspepsia—Capecitabine—breast cancer	0.000146	0.00037	CcSEcCtD
Pindolol—Visual impairment—Doxorubicin—breast cancer	0.000145	0.000367	CcSEcCtD
Pindolol—Asthenia—Paclitaxel—breast cancer	0.000145	0.000367	CcSEcCtD
Pindolol—Nausea—Gemcitabine—breast cancer	0.000144	0.000363	CcSEcCtD
Pindolol—Gastrointestinal disorder—Capecitabine—breast cancer	0.000144	0.000363	CcSEcCtD
Pindolol—Fatigue—Capecitabine—breast cancer	0.000143	0.000362	CcSEcCtD
Pindolol—Pruritus—Paclitaxel—breast cancer	0.000143	0.000362	CcSEcCtD
Pindolol—Mental disorder—Epirubicin—breast cancer	0.000143	0.000361	CcSEcCtD
Pindolol—Constipation—Capecitabine—breast cancer	0.000142	0.000359	CcSEcCtD
Pindolol—Pain—Capecitabine—breast cancer	0.000142	0.000359	CcSEcCtD
Pindolol—Feeling abnormal—Docetaxel—breast cancer	0.000141	0.000357	CcSEcCtD
Pindolol—Nausea—Fluorouracil—breast cancer	0.000141	0.000357	CcSEcCtD
Pindolol—Tinnitus—Doxorubicin—breast cancer	0.000141	0.000355	CcSEcCtD
Pindolol—Gastrointestinal pain—Docetaxel—breast cancer	0.00014	0.000355	CcSEcCtD
Pindolol—Cardiac disorder—Doxorubicin—breast cancer	0.00014	0.000354	CcSEcCtD
Pindolol—Flatulence—Epirubicin—breast cancer	0.00014	0.000353	CcSEcCtD
Pindolol—Tension—Epirubicin—breast cancer	0.000139	0.000352	CcSEcCtD
Pindolol—Diarrhoea—Paclitaxel—breast cancer	0.000139	0.00035	CcSEcCtD
Pindolol—Nervousness—Epirubicin—breast cancer	0.000138	0.000348	CcSEcCtD
Pindolol—Feeling abnormal—Capecitabine—breast cancer	0.000137	0.000346	CcSEcCtD
Pindolol—Angiopathy—Doxorubicin—breast cancer	0.000137	0.000346	CcSEcCtD
Pindolol—Muscle spasms—Epirubicin—breast cancer	0.000136	0.000345	CcSEcCtD
Pindolol—Vertigo—Methotrexate—breast cancer	0.000136	0.000344	CcSEcCtD
Pindolol—Gastrointestinal pain—Capecitabine—breast cancer	0.000136	0.000343	CcSEcCtD
Pindolol—Mediastinal disorder—Doxorubicin—breast cancer	0.000136	0.000343	CcSEcCtD
Pindolol—Abdominal pain—Docetaxel—breast cancer	0.000136	0.000343	CcSEcCtD
Pindolol—Dizziness—Paclitaxel—breast cancer	0.000134	0.000338	CcSEcCtD
Pindolol—Mental disorder—Doxorubicin—breast cancer	0.000132	0.000334	CcSEcCtD
Pindolol—Abdominal pain—Capecitabine—breast cancer	0.000131	0.000332	CcSEcCtD
Pindolol—Flatulence—Doxorubicin—breast cancer	0.000129	0.000327	CcSEcCtD
Pindolol—Chest pain—Methotrexate—breast cancer	0.000129	0.000326	CcSEcCtD
Pindolol—Arthralgia—Methotrexate—breast cancer	0.000129	0.000326	CcSEcCtD
Pindolol—Myalgia—Methotrexate—breast cancer	0.000129	0.000326	CcSEcCtD
Pindolol—Tension—Doxorubicin—breast cancer	0.000129	0.000326	CcSEcCtD
Pindolol—Vomiting—Paclitaxel—breast cancer	0.000129	0.000325	CcSEcCtD
Pindolol—Propranolol—ABCB1—breast cancer	0.000129	0.0223	CrCbGaD
Pindolol—Rash—Paclitaxel—breast cancer	0.000128	0.000323	CcSEcCtD
Pindolol—Dermatitis—Paclitaxel—breast cancer	0.000128	0.000322	CcSEcCtD
Pindolol—Nervousness—Doxorubicin—breast cancer	0.000128	0.000322	CcSEcCtD
Pindolol—Vertigo—Epirubicin—breast cancer	0.000127	0.000322	CcSEcCtD
Pindolol—Syncope—Epirubicin—breast cancer	0.000127	0.000321	CcSEcCtD
Pindolol—Headache—Paclitaxel—breast cancer	0.000127	0.000321	CcSEcCtD
Pindolol—Muscle spasms—Doxorubicin—breast cancer	0.000126	0.000319	CcSEcCtD
Pindolol—Palpitations—Epirubicin—breast cancer	0.000125	0.000317	CcSEcCtD
Pindolol—Confusional state—Methotrexate—breast cancer	0.000125	0.000315	CcSEcCtD
Pindolol—Loss of consciousness—Epirubicin—breast cancer	0.000125	0.000315	CcSEcCtD
Pindolol—Asthenia—Docetaxel—breast cancer	0.000123	0.000311	CcSEcCtD
Pindolol—Pruritus—Docetaxel—breast cancer	0.000121	0.000307	CcSEcCtD
Pindolol—Nervous system disorder—Methotrexate—breast cancer	0.000121	0.000307	CcSEcCtD
Pindolol—Chest pain—Epirubicin—breast cancer	0.000121	0.000305	CcSEcCtD
Pindolol—Myalgia—Epirubicin—breast cancer	0.000121	0.000305	CcSEcCtD
Pindolol—Arthralgia—Epirubicin—breast cancer	0.000121	0.000305	CcSEcCtD
Pindolol—Anxiety—Epirubicin—breast cancer	0.00012	0.000304	CcSEcCtD
Pindolol—Nausea—Paclitaxel—breast cancer	0.00012	0.000304	CcSEcCtD
Pindolol—Hyperhidrosis—Methotrexate—breast cancer	0.00012	0.000302	CcSEcCtD
Pindolol—Asthenia—Capecitabine—breast cancer	0.000119	0.000301	CcSEcCtD
Pindolol—Dry mouth—Epirubicin—breast cancer	0.000118	0.000298	CcSEcCtD
Pindolol—Vertigo—Doxorubicin—breast cancer	0.000118	0.000298	CcSEcCtD
Pindolol—Syncope—Doxorubicin—breast cancer	0.000118	0.000297	CcSEcCtD
Pindolol—Pruritus—Capecitabine—breast cancer	0.000118	0.000297	CcSEcCtD
Pindolol—Diarrhoea—Docetaxel—breast cancer	0.000117	0.000297	CcSEcCtD
Pindolol—Confusional state—Epirubicin—breast cancer	0.000117	0.000295	CcSEcCtD
Pindolol—Palpitations—Doxorubicin—breast cancer	0.000116	0.000293	CcSEcCtD
Pindolol—Oedema—Epirubicin—breast cancer	0.000116	0.000293	CcSEcCtD
Pindolol—Hypotension—Methotrexate—breast cancer	0.000116	0.000292	CcSEcCtD
Pindolol—Loss of consciousness—Doxorubicin—breast cancer	0.000115	0.000292	CcSEcCtD
Pindolol—Shock—Epirubicin—breast cancer	0.000114	0.000288	CcSEcCtD
Pindolol—Diarrhoea—Capecitabine—breast cancer	0.000114	0.000287	CcSEcCtD
Pindolol—Nervous system disorder—Epirubicin—breast cancer	0.000114	0.000287	CcSEcCtD
Pindolol—Dizziness—Docetaxel—breast cancer	0.000114	0.000287	CcSEcCtD
Pindolol—Tachycardia—Epirubicin—breast cancer	0.000113	0.000286	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000113	0.000285	CcSEcCtD
Pindolol—Hyperhidrosis—Epirubicin—breast cancer	0.000112	0.000283	CcSEcCtD
Pindolol—Insomnia—Methotrexate—breast cancer	0.000112	0.000283	CcSEcCtD
Pindolol—Myalgia—Doxorubicin—breast cancer	0.000112	0.000282	CcSEcCtD
Pindolol—Arthralgia—Doxorubicin—breast cancer	0.000112	0.000282	CcSEcCtD
Pindolol—Chest pain—Doxorubicin—breast cancer	0.000112	0.000282	CcSEcCtD
Pindolol—Anxiety—Doxorubicin—breast cancer	0.000111	0.000281	CcSEcCtD
Pindolol—Paraesthesia—Methotrexate—breast cancer	0.000111	0.000281	CcSEcCtD
Pindolol—Dyspnoea—Methotrexate—breast cancer	0.00011	0.000279	CcSEcCtD
Pindolol—Somnolence—Methotrexate—breast cancer	0.00011	0.000278	CcSEcCtD
Pindolol—Dizziness—Capecitabine—breast cancer	0.00011	0.000278	CcSEcCtD
Pindolol—Dry mouth—Doxorubicin—breast cancer	0.000109	0.000276	CcSEcCtD
Pindolol—Vomiting—Docetaxel—breast cancer	0.000109	0.000276	CcSEcCtD
Pindolol—Dyspepsia—Methotrexate—breast cancer	0.000109	0.000275	CcSEcCtD
Pindolol—Rash—Docetaxel—breast cancer	0.000108	0.000274	CcSEcCtD
Pindolol—Hypotension—Epirubicin—breast cancer	0.000108	0.000273	CcSEcCtD
Pindolol—Dermatitis—Docetaxel—breast cancer	0.000108	0.000273	CcSEcCtD
Pindolol—Confusional state—Doxorubicin—breast cancer	0.000108	0.000273	CcSEcCtD
Pindolol—Headache—Docetaxel—breast cancer	0.000108	0.000272	CcSEcCtD
Pindolol—Oedema—Doxorubicin—breast cancer	0.000107	0.000271	CcSEcCtD
Pindolol—Gastrointestinal disorder—Methotrexate—breast cancer	0.000107	0.00027	CcSEcCtD
Pindolol—Fatigue—Methotrexate—breast cancer	0.000107	0.00027	CcSEcCtD
Pindolol—Pain—Methotrexate—breast cancer	0.000106	0.000267	CcSEcCtD
Pindolol—Vomiting—Capecitabine—breast cancer	0.000106	0.000267	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000106	0.000267	CcSEcCtD
Pindolol—Shock—Doxorubicin—breast cancer	0.000105	0.000266	CcSEcCtD
Pindolol—Nervous system disorder—Doxorubicin—breast cancer	0.000105	0.000265	CcSEcCtD
Pindolol—Rash—Capecitabine—breast cancer	0.000105	0.000265	CcSEcCtD
Pindolol—Insomnia—Epirubicin—breast cancer	0.000105	0.000265	CcSEcCtD
Pindolol—Dermatitis—Capecitabine—breast cancer	0.000105	0.000265	CcSEcCtD
Pindolol—Tachycardia—Doxorubicin—breast cancer	0.000105	0.000264	CcSEcCtD
Pindolol—Headache—Capecitabine—breast cancer	0.000104	0.000263	CcSEcCtD
Pindolol—Paraesthesia—Epirubicin—breast cancer	0.000104	0.000263	CcSEcCtD
Pindolol—Hyperhidrosis—Doxorubicin—breast cancer	0.000104	0.000262	CcSEcCtD
Pindolol—Dyspnoea—Epirubicin—breast cancer	0.000103	0.000261	CcSEcCtD
Pindolol—Somnolence—Epirubicin—breast cancer	0.000103	0.00026	CcSEcCtD
Pindolol—Nausea—Docetaxel—breast cancer	0.000102	0.000258	CcSEcCtD
Pindolol—Feeling abnormal—Methotrexate—breast cancer	0.000102	0.000258	CcSEcCtD
Pindolol—Dyspepsia—Epirubicin—breast cancer	0.000102	0.000258	CcSEcCtD
Pindolol—Gastrointestinal pain—Methotrexate—breast cancer	0.000101	0.000256	CcSEcCtD
Pindolol—Hypotension—Doxorubicin—breast cancer	0.0001	0.000253	CcSEcCtD
Pindolol—Gastrointestinal disorder—Epirubicin—breast cancer	0.0001	0.000253	CcSEcCtD
Pindolol—Fatigue—Epirubicin—breast cancer	9.98e-05	0.000252	CcSEcCtD
Pindolol—Pain—Epirubicin—breast cancer	9.9e-05	0.00025	CcSEcCtD
Pindolol—Constipation—Epirubicin—breast cancer	9.9e-05	0.00025	CcSEcCtD
Pindolol—Nausea—Capecitabine—breast cancer	9.87e-05	0.000249	CcSEcCtD
Pindolol—Abdominal pain—Methotrexate—breast cancer	9.78e-05	0.000247	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Doxorubicin—breast cancer	9.76e-05	0.000247	CcSEcCtD
Pindolol—Insomnia—Doxorubicin—breast cancer	9.69e-05	0.000245	CcSEcCtD
Pindolol—Paraesthesia—Doxorubicin—breast cancer	9.62e-05	0.000243	CcSEcCtD
Pindolol—Dyspnoea—Doxorubicin—breast cancer	9.55e-05	0.000241	CcSEcCtD
Pindolol—Feeling abnormal—Epirubicin—breast cancer	9.54e-05	0.000241	CcSEcCtD
Pindolol—Somnolence—Doxorubicin—breast cancer	9.53e-05	0.000241	CcSEcCtD
Pindolol—Gastrointestinal pain—Epirubicin—breast cancer	9.47e-05	0.000239	CcSEcCtD
Pindolol—Dyspepsia—Doxorubicin—breast cancer	9.43e-05	0.000238	CcSEcCtD
Pindolol—Gastrointestinal disorder—Doxorubicin—breast cancer	9.25e-05	0.000234	CcSEcCtD
Pindolol—Fatigue—Doxorubicin—breast cancer	9.24e-05	0.000233	CcSEcCtD
Pindolol—Pain—Doxorubicin—breast cancer	9.16e-05	0.000232	CcSEcCtD
Pindolol—Constipation—Doxorubicin—breast cancer	9.16e-05	0.000232	CcSEcCtD
Pindolol—Abdominal pain—Epirubicin—breast cancer	9.15e-05	0.000231	CcSEcCtD
Pindolol—Asthenia—Methotrexate—breast cancer	8.88e-05	0.000224	CcSEcCtD
Pindolol—Feeling abnormal—Doxorubicin—breast cancer	8.83e-05	0.000223	CcSEcCtD
Pindolol—Gastrointestinal pain—Doxorubicin—breast cancer	8.76e-05	0.000221	CcSEcCtD
Pindolol—Pruritus—Methotrexate—breast cancer	8.75e-05	0.000221	CcSEcCtD
Pindolol—Abdominal pain—Doxorubicin—breast cancer	8.47e-05	0.000214	CcSEcCtD
Pindolol—Diarrhoea—Methotrexate—breast cancer	8.47e-05	0.000214	CcSEcCtD
Pindolol—Asthenia—Epirubicin—breast cancer	8.31e-05	0.00021	CcSEcCtD
Pindolol—Pruritus—Epirubicin—breast cancer	8.19e-05	0.000207	CcSEcCtD
Pindolol—Dizziness—Methotrexate—breast cancer	8.18e-05	0.000207	CcSEcCtD
Pindolol—Diarrhoea—Epirubicin—breast cancer	7.92e-05	0.0002	CcSEcCtD
Pindolol—Vomiting—Methotrexate—breast cancer	7.87e-05	0.000199	CcSEcCtD
Pindolol—Rash—Methotrexate—breast cancer	7.8e-05	0.000197	CcSEcCtD
Pindolol—Dermatitis—Methotrexate—breast cancer	7.8e-05	0.000197	CcSEcCtD
Pindolol—Headache—Methotrexate—breast cancer	7.75e-05	0.000196	CcSEcCtD
Pindolol—Asthenia—Doxorubicin—breast cancer	7.69e-05	0.000194	CcSEcCtD
Pindolol—Dizziness—Epirubicin—breast cancer	7.66e-05	0.000193	CcSEcCtD
Pindolol—Pruritus—Doxorubicin—breast cancer	7.58e-05	0.000192	CcSEcCtD
Pindolol—Vomiting—Epirubicin—breast cancer	7.36e-05	0.000186	CcSEcCtD
Pindolol—Nausea—Methotrexate—breast cancer	7.35e-05	0.000186	CcSEcCtD
Pindolol—Diarrhoea—Doxorubicin—breast cancer	7.33e-05	0.000185	CcSEcCtD
Pindolol—Rash—Epirubicin—breast cancer	7.3e-05	0.000184	CcSEcCtD
Pindolol—Dermatitis—Epirubicin—breast cancer	7.29e-05	0.000184	CcSEcCtD
Pindolol—Headache—Epirubicin—breast cancer	7.25e-05	0.000183	CcSEcCtD
Pindolol—Dizziness—Doxorubicin—breast cancer	7.09e-05	0.000179	CcSEcCtD
Pindolol—Nausea—Epirubicin—breast cancer	6.88e-05	0.000174	CcSEcCtD
Pindolol—Vomiting—Doxorubicin—breast cancer	6.81e-05	0.000172	CcSEcCtD
Pindolol—Rash—Doxorubicin—breast cancer	6.76e-05	0.000171	CcSEcCtD
Pindolol—Dermatitis—Doxorubicin—breast cancer	6.75e-05	0.000171	CcSEcCtD
Pindolol—Headache—Doxorubicin—breast cancer	6.71e-05	0.00017	CcSEcCtD
Pindolol—Nausea—Doxorubicin—breast cancer	6.36e-05	0.000161	CcSEcCtD
Pindolol—ADRB1—Signaling Pathways—KDR—breast cancer	1.25e-05	0.000117	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—LEP—breast cancer	1.25e-05	0.000117	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—FASN—breast cancer	1.25e-05	0.000117	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—KRAS—breast cancer	1.25e-05	0.000116	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—BCHE—breast cancer	1.25e-05	0.000116	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CAV1—breast cancer	1.24e-05	0.000116	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SLC5A5—breast cancer	1.23e-05	0.000115	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KDR—breast cancer	1.23e-05	0.000114	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—LEP—breast cancer	1.22e-05	0.000114	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ESR1—breast cancer	1.22e-05	0.000114	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CAV1—breast cancer	1.21e-05	0.000113	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—FN1—breast cancer	1.21e-05	0.000112	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NOS3—breast cancer	1.2e-05	0.000112	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KDR—breast cancer	1.2e-05	0.000112	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ESR1—breast cancer	1.2e-05	0.000111	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—SRC—breast cancer	1.2e-05	0.000111	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NFKBIA—breast cancer	1.19e-05	0.000111	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NQO1—breast cancer	1.19e-05	0.000111	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SLC2A1—breast cancer	1.19e-05	0.000111	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NOTCH1—breast cancer	1.18e-05	0.00011	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—FN1—breast cancer	1.18e-05	0.00011	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ESR1—breast cancer	1.17e-05	0.000109	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NFKBIA—breast cancer	1.17e-05	0.000109	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—VEGFA—breast cancer	1.16e-05	0.000108	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP3A4—breast cancer	1.16e-05	0.000108	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NOTCH1—breast cancer	1.16e-05	0.000108	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—KIT—breast cancer	1.16e-05	0.000108	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CG—breast cancer	1.16e-05	0.000108	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—APC—breast cancer	1.16e-05	0.000108	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—FN1—breast cancer	1.15e-05	0.000108	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—STAT3—breast cancer	1.15e-05	0.000107	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—PIK3CA—breast cancer	1.15e-05	0.000107	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MDM2—breast cancer	1.14e-05	0.000106	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EGF—breast cancer	1.14e-05	0.000106	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NFKBIA—breast cancer	1.14e-05	0.000106	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP1B1—breast cancer	1.14e-05	0.000106	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—RAF1—breast cancer	1.14e-05	0.000106	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—RELA—breast cancer	1.13e-05	0.000106	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KIT—breast cancer	1.13e-05	0.000105	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CG—breast cancer	1.13e-05	0.000105	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—APC—breast cancer	1.13e-05	0.000105	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NOTCH1—breast cancer	1.13e-05	0.000105	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—ERBB2—breast cancer	1.13e-05	0.000105	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—HSP90AA1—breast cancer	1.12e-05	0.000104	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EGF—breast cancer	1.12e-05	0.000104	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MTOR—breast cancer	1.11e-05	0.000104	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CB—breast cancer	1.11e-05	0.000104	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—MAPK3—breast cancer	1.11e-05	0.000103	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KIT—breast cancer	1.1e-05	0.000103	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CG—breast cancer	1.1e-05	0.000103	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—APC—breast cancer	1.1e-05	0.000103	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MAPK3—breast cancer	1.1e-05	0.000103	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EGF—breast cancer	1.09e-05	0.000102	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NCOA1—breast cancer	1.09e-05	0.000101	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—BRAF—breast cancer	1.09e-05	0.000101	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—MAPK3—breast cancer	1.08e-05	0.000101	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP19A1—breast cancer	1.07e-05	9.98e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—STK11—breast cancer	1.07e-05	9.98e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MYC—breast cancer	1.07e-05	9.97e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TGFB1—breast cancer	1.07e-05	9.95e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CXCL8—breast cancer	1.07e-05	9.95e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—BRAF—breast cancer	1.06e-05	9.89e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—HRAS—breast cancer	1.06e-05	9.88e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—MAPK3—breast cancer	1.06e-05	9.86e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IGF1—breast cancer	1.06e-05	9.85e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AKT2—breast cancer	1.06e-05	9.84e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—EGFR—breast cancer	1.05e-05	9.8e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—EGFR—breast cancer	1.05e-05	9.76e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CDKN1B—breast cancer	1.04e-05	9.72e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—BRAF—breast cancer	1.04e-05	9.67e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IGF1—breast cancer	1.03e-05	9.64e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AKT2—breast cancer	1.03e-05	9.63e-05	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—AKT1—breast cancer	1.03e-05	9.61e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—EGFR—breast cancer	1.03e-05	9.59e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CASP3—breast cancer	1.02e-05	9.52e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IL2—breast cancer	1.02e-05	9.51e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—IL6—breast cancer	1.02e-05	9.46e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CD—breast cancer	1.02e-05	9.46e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IGF1—breast cancer	1.01e-05	9.42e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AKT2—breast cancer	1.01e-05	9.42e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—EGFR—breast cancer	1.01e-05	9.38e-05	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	1.01e-05	9.37e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SERPINE1—breast cancer	1e-05	9.36e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—COMT—breast cancer	9.97e-06	9.28e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CCND1—breast cancer	9.95e-06	9.27e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—KRAS—breast cancer	9.94e-06	9.26e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CD—breast cancer	9.93e-06	9.25e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—JUN—breast cancer	9.93e-06	9.25e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTP1—breast cancer	9.92e-06	9.24e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—KRAS—breast cancer	9.9e-06	9.22e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CTNNB1—breast cancer	9.85e-06	9.18e-05	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	9.84e-06	9.16e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SERPINE1—breast cancer	9.83e-06	9.15e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—HMOX1—breast cancer	9.78e-06	9.11e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ITPR1—breast cancer	9.76e-06	9.09e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—KRAS—breast cancer	9.73e-06	9.06e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CD—breast cancer	9.71e-06	9.05e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MMP9—breast cancer	9.66e-06	9e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CDKN1A—breast cancer	9.63e-06	8.97e-05	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—PIK3CA—breast cancer	9.62e-06	8.96e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SERPINE1—breast cancer	9.61e-06	8.95e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PTEN—breast cancer	9.6e-06	8.95e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NOS3—breast cancer	9.59e-06	8.93e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—KRAS—breast cancer	9.51e-06	8.86e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MAPK8—breast cancer	9.4e-06	8.75e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ABCB1—breast cancer	9.39e-06	8.74e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NOS3—breast cancer	9.38e-06	8.74e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—AKT1—breast cancer	9.37e-06	8.73e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—TYMS—breast cancer	9.22e-06	8.59e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NOS3—breast cancer	9.17e-06	8.54e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	9.13e-06	8.51e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NCOR1—breast cancer	9.11e-06	8.49e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PLA2G4A—breast cancer	9.11e-06	8.49e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTM1—breast cancer	9.11e-06	8.49e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MDM2—breast cancer	9.1e-06	8.47e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PIK3CA—breast cancer	9.09e-06	8.47e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—RAF1—breast cancer	9.07e-06	8.44e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—RELA—breast cancer	9.03e-06	8.41e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ERBB2—breast cancer	8.97e-06	8.35e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	8.94e-06	8.32e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SRC—breast cancer	8.91e-06	8.3e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MDM2—breast cancer	8.9e-06	8.29e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—RAF1—breast cancer	8.87e-06	8.26e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CB—breast cancer	8.85e-06	8.24e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MTOR—breast cancer	8.85e-06	8.24e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—RELA—breast cancer	8.83e-06	8.22e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TP53—breast cancer	8.79e-06	8.19e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ERBB2—breast cancer	8.77e-06	8.17e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PIK3CA—breast cancer	8.74e-06	8.14e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GPX1—breast cancer	8.73e-06	8.13e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MDM2—breast cancer	8.7e-06	8.11e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—VEGFA—breast cancer	8.67e-06	8.08e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—RAF1—breast cancer	8.67e-06	8.08e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CB—breast cancer	8.66e-06	8.06e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MTOR—breast cancer	8.66e-06	8.06e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP1A1—breast cancer	8.64e-06	8.05e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—RELA—breast cancer	8.63e-06	8.04e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—STAT3—breast cancer	8.59e-06	8e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ERBB2—breast cancer	8.58e-06	7.99e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ERCC2—breast cancer	8.57e-06	7.98e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CXCL8—breast cancer	8.51e-06	7.92e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CB—breast cancer	8.47e-06	7.89e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MTOR—breast cancer	8.47e-06	7.89e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—HRAS—breast cancer	8.45e-06	7.87e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—HRAS—breast cancer	8.41e-06	7.83e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CXCL8—breast cancer	8.32e-06	7.75e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CDKN1B—breast cancer	8.31e-06	7.74e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—HRAS—breast cancer	8.27e-06	7.7e-05	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—AKT1—breast cancer	8.22e-06	7.65e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MAPK3—breast cancer	8.21e-06	7.64e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CASP3—breast cancer	8.14e-06	7.58e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CXCL8—breast cancer	8.14e-06	7.58e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL2—breast cancer	8.13e-06	7.57e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CDKN1B—breast cancer	8.13e-06	7.57e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—IL6—breast cancer	8.09e-06	7.53e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—HRAS—breast cancer	8.08e-06	7.53e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—MTHFR—breast cancer	8.05e-06	7.5e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IL6—breast cancer	8.05e-06	7.5e-05	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—AKT1—breast cancer	8.04e-06	7.49e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MYC—breast cancer	7.98e-06	7.43e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CASP3—breast cancer	7.96e-06	7.42e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TGFB1—breast cancer	7.96e-06	7.42e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL2—breast cancer	7.95e-06	7.41e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CDKN1B—breast cancer	7.95e-06	7.4e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CCND1—breast cancer	7.92e-06	7.38e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—IL6—breast cancer	7.91e-06	7.37e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—JUN—breast cancer	7.91e-06	7.37e-05	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—AKT1—breast cancer	7.86e-06	7.32e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CTNNB1—breast cancer	7.85e-06	7.31e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EGFR—breast cancer	7.81e-06	7.27e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CASP3—breast cancer	7.79e-06	7.25e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL2—breast cancer	7.78e-06	7.24e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CCND1—breast cancer	7.75e-06	7.22e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—IL6—breast cancer	7.74e-06	7.21e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—JUN—breast cancer	7.74e-06	7.21e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MMP9—breast cancer	7.69e-06	7.17e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CTNNB1—breast cancer	7.68e-06	7.15e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CDKN1A—breast cancer	7.67e-06	7.14e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PTEN—breast cancer	7.65e-06	7.12e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCND1—breast cancer	7.58e-06	7.06e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—JUN—breast cancer	7.56e-06	7.05e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MMP9—breast cancer	7.53e-06	7.01e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CTNNB1—breast cancer	7.51e-06	6.99e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CDKN1A—breast cancer	7.5e-06	6.98e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MAPK8—breast cancer	7.48e-06	6.97e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PTEN—breast cancer	7.48e-06	6.97e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—AKT1—breast cancer	7.46e-06	6.95e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CAV1—breast cancer	7.43e-06	6.92e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—AKT1—breast cancer	7.43e-06	6.92e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—KRAS—breast cancer	7.37e-06	6.87e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MMP9—breast cancer	7.36e-06	6.85e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CDKN1A—breast cancer	7.33e-06	6.83e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MAPK8—breast cancer	7.32e-06	6.82e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PTEN—breast cancer	7.32e-06	6.81e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—AKT1—breast cancer	7.3e-06	6.8e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MAPK8—breast cancer	7.16e-06	6.67e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—AKT1—breast cancer	7.14e-06	6.65e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SRC—breast cancer	7.09e-06	6.61e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SRC—breast cancer	6.94e-06	6.46e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—VEGFA—breast cancer	6.91e-06	6.43e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—STAT3—breast cancer	6.84e-06	6.37e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SRC—breast cancer	6.78e-06	6.32e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CA—breast cancer	6.78e-06	6.31e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CG—breast cancer	6.77e-06	6.3e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—VEGFA—breast cancer	6.76e-06	6.29e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—STAT3—breast cancer	6.69e-06	6.23e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—VEGFA—breast cancer	6.61e-06	6.16e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TP53—breast cancer	6.55e-06	6.11e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—STAT3—breast cancer	6.54e-06	6.09e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MAPK3—breast cancer	6.54e-06	6.09e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MAPK3—breast cancer	6.39e-06	5.95e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MYC—breast cancer	6.36e-06	5.92e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TGFB1—breast cancer	6.34e-06	5.91e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HRAS—breast cancer	6.27e-06	5.84e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MAPK3—breast cancer	6.25e-06	5.82e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MYC—breast cancer	6.22e-06	5.79e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EGFR—breast cancer	6.22e-06	5.79e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TGFB1—breast cancer	6.2e-06	5.78e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EGFR—breast cancer	6.08e-06	5.66e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MYC—breast cancer	6.08e-06	5.66e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TGFB1—breast cancer	6.07e-06	5.65e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IL6—breast cancer	6e-06	5.59e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CD—breast cancer	5.95e-06	5.54e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EGFR—breast cancer	5.95e-06	5.54e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—KRAS—breast cancer	5.87e-06	5.47e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALB—breast cancer	5.87e-06	5.47e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KRAS—breast cancer	5.75e-06	5.35e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NOS3—breast cancer	5.62e-06	5.23e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KRAS—breast cancer	5.62e-06	5.23e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AKT1—breast cancer	5.53e-06	5.16e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CA—breast cancer	5.4e-06	5.03e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CA—breast cancer	5.28e-06	4.92e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TP53—breast cancer	5.22e-06	4.86e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CB—breast cancer	5.19e-06	4.83e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CA—breast cancer	5.16e-06	4.81e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PTGS2—breast cancer	5.14e-06	4.79e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TP53—breast cancer	5.11e-06	4.76e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TP53—breast cancer	4.99e-06	4.65e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HRAS—breast cancer	4.99e-06	4.65e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HRAS—breast cancer	4.88e-06	4.55e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL6—breast cancer	4.78e-06	4.45e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HRAS—breast cancer	4.78e-06	4.45e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL6—breast cancer	4.67e-06	4.35e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL6—breast cancer	4.57e-06	4.26e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PTEN—breast cancer	4.48e-06	4.17e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AKT1—breast cancer	4.41e-06	4.11e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AKT1—breast cancer	4.31e-06	4.02e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AKT1—breast cancer	4.22e-06	3.93e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CA—breast cancer	3.16e-06	2.94e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AKT1—breast cancer	2.58e-06	2.41e-05	CbGpPWpGaD
